Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy—Brief Report - Hippe, Daniel S.; Phan, Binh P.; Sun, Jie; Isquith, Daniel A.; O’Brien, Kevin D.; Crouse, John R.; Anderson, Todd; Huston, John; Marcovina, Santica M.; Hatsukami, Thomas S.; Yuan, Chun; Zhao, Xue-Qiao (Arteriosclerosis, thrombosis, and vascular biology, 2018)
Keywords: Adult; Aged; Aged, 80 and over; Biomarkers - blood; Carotid Arteries - diagnostic imaging; Carotid Arteries - drug effects; Carotid Arteries - pathology; Carotid Artery Diseases - blood; Carotid Artery Diseases - diagnostic imaging; Carotid Artery Diseases - drug therapy; Carotid Artery Diseases - pathology; Cholesterol, LDL - blood; Double-Blind Method; Female; Humans; Hypolipidemic Agents - therapeutic use; Lipoprotein(a) - blood; Magnetic Resonance Angiography; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Risk Factors; Time Factors; Treatment Outcome; atherosclerosis; lipids; risk factors; lipoprotein; lp(a); triglycerides; lipoprotein(a)